Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SpinTech MRI is a private medical imaging software company focused on quantitative brain MRI. Its core commercial product, STAGE (STrategically Acquired Gradient Echo), is an FDA 510(k)-cleared software platform designed to speed brain MRI protocols, improve image quality, and generate quantitative outputs from existing 1.5T and 3T MRI systems. The company positions STAGE as a software-only solution that can reduce scan times by about 30% while supporting visualization, post-processing, and biomarker assessment relevant to neurological disease. SpinTech MRI collaborates with hospitals, imaging providers, and MRI industry partners to deploy its technology in routine clinical workflows and in neurosurgical settings. The business is healthcare-related, but it is not a therapeutics developer; it is best categorized as a commercial-stage neuroimaging software and medical device company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on SpinTech MRI.